REQUEST A DEMO
Total
USD $0.00
Search more companies

Endogyn Dr Ivan Valencia S.A.S. (Ecuador)

Main Activities: Outpatient Care Centers
Full name: Endogyn Dr Ivan Valencia S.A.S. Profile Updated: September 08, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Endogyn Dr Ivan Valencia S.A.S. is an enterprise in Ecuador, with the main office in Manta. The enterprise operates in the Outpatient Care Centers industry. The company was established on March 21, 2022. There are currently 3 (2024) people employed by Endogyn Dr Ivan Valencia S.A.S.. The company’s latest financial report indicates a net sales revenue increase of 24.54% in 2025. Over the same period, its total assets decreased by 57.8%. The enterprise’s net profit margin increased by 6.77% in 2025.

Headquarters
Calle 1.5 Km. Via Basbasquillo
Manta; Manabi;

Contact Details: Purchase the Endogyn Dr Ivan Valencia S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Endogyn Dr Ivan Valencia S.A.S. report to view the information.
Registered Capital:
Purchase the Endogyn Dr Ivan Valencia S.A.S. report to view the information.
Financial Auditors:
Purchase the Endogyn Dr Ivan Valencia S.A.S. report to view the information.
Incorporation Date:
March 21, 2022
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Endogyn Dr Ivan Valencia S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
24.54%
Total Operating Revenue
24.54%
Operating Profit
212.25%
EBITDA
212.25%
Net Profit/Loss for the Period
181.67%
Total Assets
-57.8%
Total Equity
177.55%
Operating Profit Margin
10.37%
Net Profit Margin
6.77%
Return on Equity (ROE)
0.88%
Quick Ratio
1.09%
Cash Ratio
-0.29%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?